Which antiemetic medication is recommended for treating hyperemesis due to semaglutide overdose?

Antiemetic Treatment for Semaglutide Overdose-Induced Hyperemesis

For hyperemesis caused by semaglutide overdose, use ondansetron (a 5-HT3 receptor antagonist) as first-line therapy, with metoclopramide or prochlorperazine (dopamine receptor antagonists) as alternatives if ondansetron fails.

Primary Recommendation

The management of semaglutide overdose centers on supportive care, as there is no specific antidote 1. Based on the available evidence and the mechanism of GLP-1 receptor agonist-induced nausea:

• Start with ondansetron (5-HT3 receptor antagonist) as your initial antiemetic
• This aligns with standard antiemetic therapy for gastrointestinal-mediated nausea
• Dose: 4-8 mg IV/PO every 8 hours as needed

Stepwise Escalation if First-Line Fails

If ondansetron provides inadequate relief:

1. Add or switch to metoclopramide (10 mg IV/PO every 6-8 hours)

   • Dopamine receptor antagonist with prokinetic properties
   • Addresses delayed gastric emptying caused by GLP-1 agonists

2. Consider prochlorperazine (5-10 mg IV/PO every 6-8 hours)

   • Alternative dopamine receptor antagonist
   • Case evidence shows sequential use in refractory cases 2

3. For truly refractory cases, droperidol may be considered

   • Recent evidence supports its use in severe, treatment-resistant hyperemesis 2
   • Requires cardiac monitoring (QT prolongation risk)

Clinical Context and Monitoring

The case literature reveals important nuances 1:

• GI symptoms are dose-dependent with semaglutide, but overdose presentations vary widely
• Some patients remain completely asymptomatic despite significant overdoses (7 mg over 7 days in one case)
• When symptoms occur, they typically manifest as nausea, vomiting, abdominal pain, and diarrhea

Critical monitoring parameters:

• Fluid and electrolyte status (correct dehydration and imbalances from GI losses)
• Blood glucose (monitor for hypoglycemia, though less common than expected)
• Renal function (risk of acute kidney injury from volume depletion)
• Pancreatic enzymes if severe abdominal pain develops (pancreatitis risk)

Common Pitfalls to Avoid

• Don't assume severe symptoms will occur - overdose presentation is unpredictable
• Don't neglect fluid resuscitation - dehydration from GI losses can cause acute kidney injury 1
• Don't use antiemetics alone - supportive care with IV fluids is equally important
• Don't discharge without ensuring adequate oral intake - delayed gastric emptying persists beyond acute symptoms 3

The evidence base for specific antiemetic choice in semaglutide overdose is limited, as published cases describe "supportive care with antiemetics" without specifying agents 1. The recommendation for 5-HT3 antagonists and dopamine receptor antagonists is extrapolated from general antiemetic guidelines 4 and the pathophysiology of GLP-1-induced nausea, which involves both central and peripheral mechanisms affecting gastric motility.